Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 2OQ3OPV2F8

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT Fibronectin binding agent PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Melanoma 3 D008545 ClinicalTrials
Melanoma 3 D008545 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Pancreatic Neoplasms 1 D010190 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109608
FDA SRS 2OQ3OPV2F8